Uptake of propranolol, a cardiovascular pharmaceutical, from water into fish plasma and its effects on growth and organ biometry.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Aquatic Toxicology

• Publication date

  2009-07-26

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.aquatox.2009.05.009PMID 19515433
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evolutionary conservation of human drug targets in organisms used for environmental risk assessments.

  2008cited by this paper
• Pharmaceuticals in the environment : sources, fate, effects and risks

  2008cited by this paper
• Comparative physiology, pharmacology and toxicology of beta-blockers: mammals versus fish.

  2007cited by this paper
• Environmental Effects of Human Pharmaceuticals

  2007cited by this paper
• Repeating history: pharmaceuticals in the environment.

  2007cited by this paper
• Effluent from drug manufactures contains extremely high levels of pharmaceuticals.

  2007cited by this paper
• Ecotoxicology of human pharmaceuticals.

  2006cited by this paper
• Is heart rate in fish a sensitive indicator to evaluate acute effects of β-blockers in surface water?

  2006cited by this paper
• In vitro assessment of modes of toxic action of pharmaceuticals in aquatic life.

  2005cited by this paper
• In vivo drug discovery in the zebrafish

  2005cited by this paper
• Plasma Concentrations of Human Pharmaceuticals as Predictors of Pharmacological Responses in Fish

  2004cited by this paper
• Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom.

  2004cited by this paper
• Environmental risk assessment of six human pharmaceuticals: Are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?

  2004cited by this paper
• The rainbow trout skeletal muscle beta-adrenergic system: characterization and signaling.

  2003cited by this paper
• Determination of beta-adrenergic receptor blocking pharmaceuticals in United States wastewater effluent.

  2003cited by this paper
• Relative potencies and combination effects of steroidal estrogens in fish.

  2003cited by this paper
• Determination of selected human pharmaceutical compounds in effluent and surface water samples by high-performance liquid chromatography-electrospray tandem mass spectrometry.

  2003cited by this paper
• Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater?

  2003cited by this paper
• Activity of the unique beta-adrenergic Na+/H+ exchanger in trout erythrocytes is controlled by a novel beta3-AR subtype.

  2003cited by this paper
• Toxicity of Select Beta Adrenergic Receptor-Blocking Pharmaceuticals (B-Blockers) on Aquatic Organisms

  2002cited by this paper
• Environmental risk assessment of pharmaceutical drug substances--conceptual considerations.

  2002cited by this paper
• A putative β2‐adrenoceptor from the rainbow trout (Oncorhynuchus mykiss)

  2001cited by this paper
• Development of a high throughput equilibrium dialysis method.

  2001cited by this paper
• Branchial elimination of superhydrophobic organic compounds by rainbow trout (Oncorhynchus mykiss).

  2001cited by this paper
• A putative beta2-adrenoceptor from the rainbow trout (Oncorhynuchus mykiss). Molecular characterization and pharmacology.

  2001cited by this paper
• Sorption of very hydrophobic organic compounds (VHOCs) on dissolved humic organic matter (DOM). 2. Measurement of sorption and application of a Flory-Huggins concept to interpret the data.

  2001cited by this paper
• Does membrane fluidity contribute to thermal compensation of beta-adrenergic signal transduction in isolated trout hepatocytes?

  2000cited by this paper
• Regulation of glucose production in rainbow trout: role of epinephrine in vivo and in isolated hepatocytes.

  2000cited by this paper
• The acute humoral adrenergic stress response in fish: facts and fiction

  1999cited by this paper
• The use of percentages and size-specific indices to normalize physiological data for variation in body size: wasted time, wasted effort?

  1999cited by this paper
• Comparisons of acute toxicity of selected chemicals to rainbow trout and rats.

  1998cited by this paper
• Occurrence of drugs in German sewage treatment plants and rivers 1 Dedicated to Professor Dr. Klaus

  1998cited by this paper
• Structure and function of the beta 3-adrenergic receptor.

  1997cited by this paper
• Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.

  1995cited by this paper
• Beta-adrenoreceptors in the trout (Oncorhynchus mykiss) heart: characterization, quantification, and effects of repeated catecholamine exposure.

  1994cited by this paper
• THERMAL ACCLIMATION ALTERS BOTH ADRENERGIC SENSITIVITY AND ADRENOCEPTOR DENSITY IN CARDIAC TISSUE OF RAINBOW TROUT

  1993cited by this paper
• Rainbow trout hepatocyte beta-adrenoceptors, catecholamine responsiveness, and effects of cortisol.

  1992cited by this paper
• Physiologically based toxicokinetic modeling of three waterborne chloroethanes in rainbow trout (Oncorhynchus mykiss).

  1991cited by this paper
• Propranolol inhibits O2-sensitive chemoreceptor activity in trout gills.

  1990cited by this paper
• The selection of suitable indices for the measurement and analysis of fish condition

  1989cited by this paper
• Quantitative account of propranolol metabolism in urine of normal man.

  1985cited by this paper
• Assessment of autonomic function in humans by heart rate spectral analysis.

  1985cited by this paper
• Studies of the Absorption and Removal of Propranolol in Hypertensive Patients during Therapy

  1975cited by this paper

• Morphological and functional response of Mytilus galloprovincialis exposed to the Enalapril metabolite, Enalaprilat.

  2025cites this paper
• Oxidative and physiological effects of carvedilol, a beta–blocker, in Daphnia magna

  2024cites this paper
• The effects of ACE inhibitor Enalapril on Mytilus galloprovincialis: Insights into morphological and functional responses.

  2024cites this paper
• Cross‐Species Extrapolation of Biological Data to Guide the Environmental Safety Assessment of Pharmaceuticals—The State of the Art and Future Priorities

  2023cites this paper
• Beyond the patient: Advanced techniques to help predict the fate and effects of pharmaceuticals in the environment

  2021cites this paper
• Effect of Water pH on the Uptake of Acidic (Ibuprofen) and Basic (Propranolol) Drugs in a Fish Gill Cell Culture Model.

  2021cites this paper
• Contrast-enhanced ultrasound imaging for assessing organ perfusion in rainbow trout (Oncorhynchus mykiss).

  2021cites this paper
• Carryover effects minimized the positive effects of treated wastewater on anuran development.

  2021cites this paper
• Environmentally relevant levels of four psychoactive compounds vary in their effects on freshwater fish condition: a brain concentration evidence approach

  2020cites this paper
• Trout and Human Plasma Protein Binding of Selected Pharmaceuticals Informs the Fish Plasma Model

  2020cites this paper
• Immunodetection of heat shock protein 70 and cell death in liver of a neotropical fish acutely and chronically exposed to acetaminophen and propranolol

  2020cites this paper
• Depressed, hypertense and sore: Long-term effects of fluoxetine, propranolol and diclofenac exposure in a top predator fish.

  2020cites this paper
• Cardiovascular drugs and lipid regulating agents in surface waters at global scale: Occurrence, ecotoxicity and risk assessment.

  2020cites this paper
• Enantiospecific toxicity, distribution and bioaccumulation of chiral antidepressant venlafaxine and its metabolite in loach (Misgurnus anguillicaudatus) co-exposed to microplastic and the drugs.

  2019cites this paper
• Biomonitoring of pesticides, pharmaceuticals and illicit drugs in a freshwater invertebrate to estimate toxic or effect pressure

  2019cites this paper
• Uptake and Effects of the Beta‐Adrenergic Agonist Salbutamol in Fish: Supporting Evidence for the Fish Plasma Model

  2019influential citation
• Environmental risk assessment of propranolol in the groundwater bodies of Europe.

  2019cites this paper
• Occurrence, fate, persistence and remediation of caffeine: a review

  2019cites this paper
• Worms on drugs: ecotoxicological effects of acetylsalicylic acid on the Polychaeta species Hediste diversicolor in terms of biochemical and histological alterations

  2019cites this paper
• Impact of Pharmaceutically Active Compounds in Marine Environment on Aquaculture

  2018cites this paper
• Characterization of a β2 adrenergic receptor protein precursor in the European eel (Anguilla anguilla) and its tissue distribution across silvering.

  2018cites this paper
• Spheroid Size Does not Impact Metabolism of the β-blocker Propranolol in 3D Intestinal Fish Model

  2018cites this paper
• Synthesis and Evaluation of a Molecularly Imprinted Polymer for the Determination of Metronidazole in Water Samples

  2018cites this paper
• Fate and effects of ionisable organic compounds and nanoparticles: At the interface of theory and experimentation

  2018cites this paper
• Influence of pH on the uptake and toxicity of β-blockers in embryos of zebrafish, Danio rerio.

  2018cites this paper
• Water Management and the Environment: Case Studies

  2018cites this paper
• Sustainable Aquaculture

  2018cites this paper
• Uptake and Metabolism of Human Pharmaceuticals by Fish: A Case Study with the Opioid Analgesic Tramadol.

  2017cites this paper
• Ecotoxicological Studies of Pharmaceuticals in Aquatic Organisms

  2017cites this paper
• Physiological responses of Nile tilapia (Oreochromis niloticus) after exposure to diclofenac and metoprolol

  2017cites this paper
• Predictive framework for estimating exposure of birds to pharmaceuticals

  2017cites this paper
• Life‐cycle exposure of fathead minnows to environmentally relevant concentrations of the β‐blocker drug propranolol

  2017cites this paper
• Chronic exposure to the ß-blocker metoprolol reduces growth and alters gene expression of gonadotropins and vitellogenin in Nile tilapia (Oreochromis niloticus).

  2017cites this paper
• Pharmaceutical Metabolism in Fish: Using a 3-D Hepatic In Vitro Model to Assess Clearance

  2017cites this paper
• Chronic effects of carbamazepine on Danio rerio: a multi-parametric evaluation

  2017cites this paper
• The sub-lethal impacts of waste water effluent and its components on Gammarus pulex

  2017cites this paper
• Water and Aquatic Fauna on Drugs: What are the Impacts of Pharmaceutical Pollution?

  2017cites this paper
• Bioaccumulation and analytics of pharmaceutical residues in the environment: A review.

  2016cites this paper
• Adrenergic signaling in teleost fish liver, a challenging path.

  2016cites this paper
• Derivation of water quality guidelines for priority pharmaceuticals

  2016cites this paper
• Bioaccumulation and biotransformation of the beta-blocker propranolol in multigenerational exposure to Daphnia magna.

  2016cites this paper
• Assessing Potential Vulnerability and Response of Fish to Simulated Avian Predation after Exposure to Psychotropic Pharmaceuticals

  2016cites this paper
• Behavioral and biochemical adjustments of the zebrafish Danio rerio exposed to the β-blocker propranolol.

  2016cites this paper
• Oxidative effects of the pharmaceutical drug paracetamol on the edible clam Ruditapes philippinarum under different salinities.

  2016cites this paper
• Human pharmaceuticals in the marine environment: Focus on exposure and biological effects in animal species

  2016cites this paper
• Biological fate and effects of propranolol in an experimental aquatic food chain.

  2015cites this paper
• A primary fish gill cell culture model to assess pharmaceutical uptake and efflux: Evidence for passive and facilitated transport

  2015influential citation
• Inhibitory effects of pain relief drugs on neurological enzymes: implications on their potential neurotoxicity to aquatic animals.

  2015cites this paper
• Transcriptional Responses in Adult Zebrafish (Danio rerio) Exposed to Propranolol and Metoprolol

  2015cites this paper
• Bioassays Currently Available for Evaluating the Biological Potency of Pharmaceuticals in Treated Wastewater

  2015cites this paper
• Mechanistic approach to predicting the sorption characteristics of pharmaceuticals

  2015cites this paper
• Toxicity and enantiospecific differences of two β‐blockers, propranolol and metoprolol, in the embryos and larvae of zebrafish (Danio rerio)

  2014cites this paper
• Comparative metabolism as a key driver of wildlife species sensitivity to human and veterinary pharmaceuticals

  2014cites this paper
• The sub-lethal effects and tissue concentration of the human pharmaceutical atenolol in rainbow trout (Oncorhynchus mykiss).

  2014cites this paper
• Pharmaceuticals in the Surface Water of the USA: A Review

  2014cites this paper
• An integrated approach for prioritizing pharmaceuticals found in the environment for risk assessment, monitoring and advanced research.

  2014cites this paper
• Similar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environments.

  2014cites this paper
• An assessment of the risks posed by human pharmaceuticals in the environment to wild birds

  2014cites this paper
• The applicability of the "read-across hypothesis" for assessing the effects of human pharmaceuticals on fish

  2014cites this paper
• The Read-Across Hypothesis and Environmental Risk Assessment of Pharmaceuticals

  2013cites this paper
• The mode of action (MOA) approach reveals interactive effects of environmental pharmaceuticals on Mytilus galloprovincialis.

  2013cites this paper
• The determination of pharmaceutical residues in cooked and uncooked marine bivalves using pressurised liquid extraction, solid-phase extraction and liquid chromatography–tandem mass spectrometry

  2013cites this paper
• Pharmaceuticals in the Built and Natural Water Environment of the United States

  2013cites this paper
• Analysis of Pharmaceutical Compounds in Biota

  2013cites this paper
• Implementing Ecopharmacovigilance in Practice: Challenges and Potential Opportunities

  2013cites this paper
• The Physiological and Behavioural Adjustments of the Zebrafish 'Danio rerio' Exposed to the β-blocker Propranolol

  2013influential citation
• The utility of trout hepatic cells in the prediction of xenobiotic bioaccumulation and environmental persistence

  2013cites this paper
• Effects of exposure to the β-blocker propranolol on the reproductive behavior and gene expression of the fathead minnow, Pimephales promelas.

  2012cites this paper
• Chiral pharmaceuticals in the environment

  2012cites this paper
• Environmental risk assessment and human pharmaceuticals : limitations and future improvements

  2012cites this paper
• Environmental Fate of Chiral Pharmaceuticals: Determination, Degradation and Toxicity

  2012cites this paper
• Environmental Comparative Pharmacology: Theory and Application

  2012cites this paper
• Effects of propranolol on heart rate and development in Japanese medaka (Oryzias latipes) and zebrafish (Danio rerio).

  2012cites this paper
• The toxicity potential of pharmaceuticals found in the Douro River estuary (Portugal): evaluation of impacts on fish liver, by histopathology, stereology, vitellogenin and CYP1A immunohistochemistry, after sub-acute exposures of the zebrafish model.

  2012cites this paper
• Studies on photodegradation of levomepromazine and olanzapine under simulated environmental conditions

  2012cites this paper
• Multi-residue method for trace level determination of pharmaceuticals in environmental samples using liquid chromatography coupled to triple quadrupole mass spectrometry.

  2012cites this paper
• In vivo and in vitro liver and gill EROD activity in rainbow trout (Oncorhynchus mykiss) exposed to the beta‐blocker propranolol

  2012cites this paper
• Pharmaceuticals in biota in the aquatic environment: analytical methods and environmental implications

  2012cites this paper
• Venlafaxine and atenolol disrupt epinephrine-stimulated glucose production in rainbow trout hepatocytes.

  2012cites this paper
• Evaluation of an isotope dilution liquid chromatography tandem mass spectrometry method for pharmaceuticals in fish.

  2012cites this paper
• Global hepatic gene expression in rainbow trout exposed to sewage effluents: a comparison of different sewage treatment technologies.

  2012cites this paper
• The β-blocker propranolol affects cAMP-dependent signaling and induces the stress response in Mediterranean mussels, Mytilus galloprovincialis.

  2011cites this paper
• Pharmaceutical residues in aquatic systems: mode of action and effects on mussel physiology

  2011cites this paper
• Characterisation and expression of β1-, β2- and β3-adrenergic receptors in the fathead minnow (Pimephales promelas).

  2011cites this paper
• Synthetic glucocorticoids in the aquatic environment : their potential impacts on fish

  2011cites this paper
• Stress and metabolic responses to municipal wastewater effluent exposure in rainbow trout effluent

  2011cites this paper
• Active Pharmaceutical Ingredients andAquatic Organisms

  2011influential citation
• Integrated testing strategy for the study of the effects of the human pharmaceutical dutasteride on fish

  2011cites this paper
• Uptake and metabolism of pharmaceuticals in aquatic invertebrates

  2011cites this paper
• HORMONAL RESPONSES TO STRESS | Stress Effect on Growth and Metabolism

  2011cites this paper
• β-blockers as endocrine disruptors: the potential effects of human β-blockers on aquatic organisms.

  2011cites this paper
• Pharmacokinetics of Propranolol Hydrochlorid in Human Urine by Capillary Electrophoresis Coupled with Electrochemiluminescence

  2011cites this paper
• Predicted critical environmental concentrations for 500 pharmaceuticals.

  2010cites this paper
• "Active Pharmaceutical Ingredients and Aquatic Organisms" Chapter in: Bayer N and Meador J. (eds) Environmental Contaminants in Biota: Interpreting Tissue Concentrations, 2nd Ed. Taylor and Francis

  2010cites this paper
• Using data from drug discovery and development to aid the aquatic environmental risk assessment of human pharmaceuticals: Concepts, considerations, and challenges

  2010cites this paper
• The value of repeating studies and multiple controls: replicated 28‐day growth studies of rainbow trout exposed to clofibric acid

  2010cites this paper
• Pharmaceuticals and Personal Care Products in the Environment COMPARATIVE AQUATIC TOXICITY OF PROPRANOLOL AND ITS PHOTODEGRADED MIXTURES: ALGAE AND ROTIFER SCREENING

  2009cites this paper
• Pharmaceuticals and personal care products: Research needs for the next decade

  2009cites this paper
• Chronic effects assessment and plasma concentrations of the beta-blocker propranolol in fathead minnows (Pimephales promelas).

  2009cites this paper
• Effects of Pollution on Freshwater Organisms

  2008cites this paper